Literature DB >> 7512034

Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway?

F Vignaux1, P Golstein.   

Abstract

To investigate the possibility that Fas-based immune regulation and Fas-based T cell-mediated cytotoxicity (F-CMC) are causally related, we explored the latter in activated lymphocyte populations. These were shown to contain effector cells exerting cytotoxicity via an F-CMC mechanism which could be differentially triggered by PMA and ionomycin. F-CMC operated in trans, requiring an lpr (Fas) product on target cells and a gld product on effector cells. Activated lymphocyte populations were also shown to contain F-CMC target cells. Activated lymphocyte populations thus contained both effector and target F-CMC cells, which could lyse each other. Fas-based cytotoxicity can thus lead to the lysis of syngeneic activated lymphocytes, consistent with the possibility of its participation in the down-regulation of immune responses, and more generally offering a model of socially controlled, direct membrane-mediated cell death.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7512034     DOI: 10.1002/eji.1830240421

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  36 in total

Review 1.  Treatment of an autoimmune disease with "classical" T cell veto: a proposal.

Authors:  U D Staerz; Y Qi
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

2.  Increased levels of soluble Fas ligand in serum in Plasmodium falciparum malaria.

Authors:  P Kern; M Dietrich; C Hemmer; N Wellinghausen
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

3.  CD4+ T cells derived from B cell-deficient mice inhibit the establishment of peripheral B cell pools.

Authors:  N Baumgarth; G C Jager; O C Herman; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

4.  Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation.

Authors:  T A Graubert; J F DiPersio; J H Russell; T J Ley
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

5.  Amplification of Fas-mediated apoptosis in type II cells via microdomain recruitment.

Authors:  Patrick Legembre; Sophie Daburon; Patrick Moreau; François Ichas; Francesca de Giorgi; Jean-François Moreau; Jean-Luc Taupin
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

6.  Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression.

Authors:  L B Owen-Schaub; W Zhang; J C Cusack; L S Angelo; S M Santee; T Fujiwara; J A Roth; A B Deisseroth; W W Zhang; E Kruzel
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

Review 7.  Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

Authors:  C C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

8.  Functional role of CD95 ligand in concanavalin A-induced intestinal intraepithelial lymphocyte cytotoxicity.

Authors:  K Ghoreschi; M Muders; G A Enders
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

9.  Effects of antigen presentation on superantigen-induced apoptosis mediated by Fas/Fas ligand interactions in human T cells.

Authors:  M Boshell; J McLeod; L Walker; N Hall; Y Patel; D Sansom
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

10.  Interleukin-18 protects mice against acute herpes simplex virus type 1 infection.

Authors:  N Fujioka; R Akazawa; K Ohashi; M Fujii; M Ikeda; M Kurimoto
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.